Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes

Volumn 44, Issue 5, 2007, Pages 525-530

  Chen, Ray Y ^a,b,e   Westfall, Andrew O ^c   Hardin, J Michael ^c   Miller Hardwick, Cassandra ^b,f   Stringer, Jeffrey S A ^c   Raper, James L ^a   Vermund, Sten H ^a,c,g   Gotuzzo, Eduardo ^d   Allison, Jeroan ^a   Saag, Michael S ^a,c  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; CD4+ cell count; Complete blood cell count; Decision tree; HIV; Total lymphocyte count

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN;

ADULT; AGED; ALGORITHM; ARTICLE; BIOLOGICAL MONITORING; BLOOD CELL COUNT; BODY MASS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; THROMBOCYTE COUNT; ZAMBIA;

ADOLESCENT; ADULT; AGED; ALGORITHMS; BLOOD CELL COUNT; CD4 LYMPHOCYTE COUNT; DATABASES, FACTUAL; DECISION TREES; DEVELOPING COUNTRIES; FEMALE; HEMOGLOBINS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PLATELET COUNT; ROC CURVE;

EID: 34247140902     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318032385e     Document Type: Article

References (45)

1. Kumarasamy N, Flanigan TP, Mahajan AP, et al. Monitoring HIV treatment in the developing world. Lancet Infect Dis. 2002;2:656-657.
2. Stephenson J. Cheaper HIV drugs for poor nations bring a new challenge: monitoring treatment. JAMA. 2002;288:151-153.
3. World Health Organization. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach, 2003 Revision. Geneva: World Health Organization; 2004.
4. Schreibman T, Friedland G. Use of total lymphocyte count for monitoring response to antiretroviral therapy. Clin Infect Dis. 2004;38:257-262.
5. Crowe S, Turnbull S, Oelrichs R, et al. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin Infect Dis. 2003;37(Suppl 1):S25-S35.
6. Montaner JS, Le TN, Le N, et al. Application of the World Health Organization system for HIV infection in a cohort of homosexual men in developing a prognostically meaningful staging system. AIDS. 1992;6:719-724.
7. Blatt SP, Lucey CR, Butzin CA, et al. Total lymphocyte count as a predictor of absolute CD4+ count and CD4+ percentage in HIV-infected persons. JAMA. 1993;269:622-626.
8. Martin DJ, Sim JG, Sole GJ, et al. CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:386-391.
9. Schechter MT, Le N, Craib KJ, et al. Use of the Markov model to estimate the waiting times in a modified WHO staging system for HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:474-479.
10. Beck EJ, Kupek EJ, Gompels MM, et al. Correlation between total and CD4 lymphocyte counts in HIV infection: not making the good an enemy of the not so perfect. Int J STD AIDS. 1996;7:422-428.
11. Wood R, Post F. Total lymphocyte count as a surrogate for CD4+ lymphocyte count in African patients coinfected with HIV and tuberculosis. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11:411-413.
12. Badri M, Wood R. Usefulness of total lymphocyte count in monitoring highly active antiretroviral therapy in resource-limited settings. AIDS. 2003;17:541-545.
13. Kumarasamy N, Mahajan AP, Flanigan TP, et al. Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002;31:378-383.
14. Gange SJ, Lau B, Phair J, et al. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. AIDS. 2003;17:119-121.
15. Bedell R, Heath KV, Hogg RS, et al. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Antivir Ther. 2003;8:379-384.
16. Lee SS, Wong KH. The use of total lymphocyte count (TLC) as an independent criterion for initiating HAART in resource-poor countries. J Infect. 2005;50:66-67.
17. Stebbing J, Sawleshwarkar S, Michailidis C, et al. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people. Postgrad Med J. 2005;81:586-588.
18. van der Ryst E, Kotze M, Joubert G, et al. Correlation among total lymphocyte count, absolute CD4+ count, and CD4+ percentage in a group of HIV-1-infected South African patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:238-244.
19. Akanmu AS, Akinsete I, Eshofonie AO, et al. Absolute lymphocyte count as surrogate for CD4+ cell count in monitoring response to antiretroviral therapy. Niger Postgrad Med J. 2001;8:105-111.
20. Liotta G, Perno CF, Ceffa S, et al. Is total lymphocyte count a reliable predictor of the CD4 lymphocyte cell count in resource-limited settings? AIDS. 2004;18:1082-1083.
21. Akinola NO, Olasode O, Adediran IA, et al. The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting. Clin Infect Dis. 2004;39:579-581.
22. Kamya MR, Semitala FC, Quinn TC, et al. Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda. Afr Health Sci. 2004;4:94-101.
23. Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA Study Group. AIDS. 1999;13:943-950.
24. Glatt AE, Anand A. Thrombocytopenia in patients infected with human immunodeficiency virus: treatment update. Clin Infect Dis. 1995;21:415-423.
25. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:80-85.
26. Maas JJ, Dukers N, Krol A, et al. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:254-259.
27. Lau B, Gange SJ, Phair JP, et al. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men. AIDS. 2003;17:2035-2044.
28. Spacek LA, Griswold M, Quinn TC, et al. Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings. AIDS. 2003;17:1311-1317.
29. Schechter M, Zajdenverg R, Machado LL, et al. Predicting CD4 counts in HIV-infected Brazilian individuals: a model based on the World Health Organization staging system. J Acquir Immune Defic Syndr. 1994;7:163-168.
30. Mwamburi DM, Ghosh M, Fauntleroy J, et al. Predicting CD4 count using total lymphocyte count: a sustainable tool for clinical decisions during HAART use. Am J Trop Med Hyg. 2005;73:58-62.
31. Costello C, Nelson KE, Jamieson DJ, et al. Predictors of low CD4 count in resource-limited settings: based on an antiretroviral-naive heterosexual Thai population. J Acquir Immune Defic Syndr. 2005;39:242-248.
32. Zhang HP, Singer B. Recursive Partitioning in the Health Sciences. New York: Springer; 1999.
33. Kass GV. An exploratory technique for investigating large quantities of categorical data. Appl Stat. 1980;29:119-127.
34. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
35. De Long DM. Sample 520: nonparametric comparison of areas under correlated ROC curves. Available at: http://support.sas.com/ctx/samples/index. jsp?sid=520. Accessed April 6, 2006.
36. Kammerer JS, McNabb SJ, Becerra JE, et al. Tuberculosis transmission in nontraditional settings: a decision-tree approach. Am J Prev Med. 2005;28:201-207.
37. Cancre N, Bois F, Gresenguet G, et al. Screening blood donations for hepatitis C in Central Africa: analysis of a risk- and cost-based decision tree. Med Decis Making. 1999;19:296-306.
38. El-Solh A, Mylotte J, Sherif S, et al. Validity of a decision tree for predicting active pulmonary tuberculosis. Am J Respir Crit Care Med. 1997;155:1711-1716.
39. Fakhir S, Ahmad P, Faridi MA, et al. Cell-mediated immune responses in malnourished host. J Trop Pediatr. 1989;35:175-178.
40. Ozkan H, Olgun N, Sasmaz E, et al. Nutrition, immunity and infections: T lymphocyte subpopulations in protein-energy malnutrition. J Trop Pediatr. 1993;39:257-260.
41. Greenberg PL, Gordeuk V, Issaragrisil S, et al. Major hematologic diseases in the developing world - new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematology (Am Soc Hematol Educ Program). 2001;479-498.
42. Yip R. Iron deficiency: contemporary scientific issues and international programmatic approaches. J Nutr. 1994;124(8 Suppl):1479S-1490S.
43. Diallo D, Tchernia G. Sickle cell disease in Africa. Curr Opin Hematol. 2002;9:111-116.
44. Ferris DC, Dawood H, Magula NP, et al. Application of an algorithm to predict CD4 lymphocyte count below 200 cells/mm(3) in HIV-infected patients in South Africa. AIDS. 2004;18:1481-1482.
45. Vermund SH, Powderly WG. Developing a human immunodeficiency virus/acquired immunodeficiency syndrome therapeutic research agenda for resource-limited countries: a consensus statement. Clin Infect Dis. 2003;37(Suppl 1):S4-S12.